Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Schechter

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Tropical Medicine & International Health : TM & IH|December 17, 2009
Mortality after failure of antiretroviral therapy in sub-Saharan AfricaOlivia Keiser, Hannock Tweya, Paula Braitstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2018
Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and EmtricitabineDavid V Glidden, Kathleen Mulligan, Vanessa McMahan, et al.
Plos One|September 7, 2012
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infectionElizabeth Hamlyn, Fiona M Ewings, Kholoud Porter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2017
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure ProphylaxisDavid V Glidden, Kathleen Mulligan, Vanessa McMahan, et al.
Plos One|November 9, 2013
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapyWolfgang Stöhr, Sarah Fidler, Myra McClure, et al.
AIDS (London, England)|August 28, 2009
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trialsChristine Katlama, Richard Haubrich, Jacob Lalezari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, BrazilAntonio G Pacheco, Suely H Tuboi, Silvia B May, et al.
Plos One|April 15, 2014
Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide dataAdelzon A Paula, Mauro Schechter, Suely H Tuboi, et al.
AIDS (London, England)|April 15, 2015
The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levelsElizabeth Hamlyn, Wolfgang Stöhr, David A Cooper, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Tropical Medicine & International Health : TM & IH|December 17, 2009
Mortality after failure of antiretroviral therapy in sub-Saharan AfricaOlivia Keiser, Hannock Tweya, Paula Braitstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2018
Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and EmtricitabineDavid V Glidden, Kathleen Mulligan, Vanessa McMahan, et al.
Plos One|September 7, 2012
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infectionElizabeth Hamlyn, Fiona M Ewings, Kholoud Porter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2016
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV InfectionJohn Thornhill, Jamie Inshaw, Pontiano Kaleebu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2017
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure ProphylaxisDavid V Glidden, Kathleen Mulligan, Vanessa McMahan, et al.
Plos One|November 9, 2013
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapyWolfgang Stöhr, Sarah Fidler, Myra McClure, et al.
AIDS (London, England)|August 28, 2009
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trialsChristine Katlama, Richard Haubrich, Jacob Lalezari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, BrazilAntonio G Pacheco, Suely H Tuboi, Silvia B May, et al.
Plos One|April 15, 2014
Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide dataAdelzon A Paula, Mauro Schechter, Suely H Tuboi, et al.
AIDS (London, England)|April 15, 2015
The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levelsElizabeth Hamlyn, Wolfgang Stöhr, David A Cooper, et al.
Pageof 12